Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Operating Expenses | 41,698 | 24,116 | 0 | 0 | 0 |
| Operating Income | -41,698 | -24,116 | N/A | N/A | N/A |
| Other Income | 338 | 653 | 0 | 0 | 0 |
| Pre-tax Income | -41,360 | -23,463 | 0 | 0 | 0 |
| Net Income Continuous | -41,360 | -23,463 | N/A | N/A | N/A |
| Net Income | $-41,360 | $-23,463 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -14.12 | -133.60 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -11.88 | -133.61 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -14.12 | -133.60 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -11.88 | -133.61 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -14.12 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-41,479 | $-24,102 | $N/A | $N/A | $N/A |